B
EXAS

Baird’s Exact Sciences EXAS Stock Holding History

Baird’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$12.3M Buy
556,575
+114,342
+26% +$2.9M 0.13% 190
2014
Q4 		$12.1M Buy
442,233
+67,654
+18% +$1.65M 0.13% 192
2014
Q3 		$7.26M Buy
374,579
+54,402
+17% +$997K 0.1% 193
2014
Q2 		$5.45M Sell
320,177
-46,191
-13% -$636K 0.08% 238
2014
Q1 		$5.19M Buy
366,368
+152,260
+71% +$2.06M 0.08% 260
2013
Q4 		$2.52M Buy
214,108
+91,191
+74% +$1.05M 0.04% 409
2013
Q3 		$1.45M Sell
122,917
-84,804
-41% -$1.09M 0.03% 499
2013
Q2 		$2.89M Buy
+207,721
New +$2.26M 0.06% 341

Other funds holding EXAS

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baird's EXAS Position: Q1 2015 in Review

Baird increased its Exact Sciences (EXAS) stake by 26% in Q1 2015, buying an estimated $2.9M and bringing the position to 556,575 shares worth $12.3M. The position accounts for 0.13% of the portfolio, ranked #190.

Baird first reported a position in EXAS in Q2 2013 and has held it in 8 quarters since. 182 funds tracked by Wall St. Rank hold EXAS as of Q1 2015.

  • Baird held 556,575 shares of Exact Sciences worth $12.3M as of Q1 2015.
  • Baird bought 114,342 Exact Sciences shares in Q1 2015, an estimated $2.9M.
  • Exact Sciences made up 0.13% of Baird's portfolio in Q1 2015, its #190 holding.
  • Baird first reported a position in Exact Sciences in Q2 2013 and has held it in 8 quarters since.
  • 182 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.